![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 3, 1620-1629, January 20, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B-dependent Anti-apoptosis through Inhibiting Recruitment of CREB-binding Protein/p300 Coactivator*
From the Department of Biochemical Genetics, Medical Research Institute, and Laboratory of Genome Structure and Regulation, School of Biomedical Science, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
Activating transcription factor (ATF) 3 plays a role in determining cell fate and generates a variety of alternatively spliced isoforms in stress response. We have reported previously that splice variant ATF3
Zip2, which lacks the leucine zipper region, is induced in response to various stress stimuli. However, its biological function has not been elucidated. By using cells treated with tumor necrosis factor-
and actinomycin D or cells overexpressing ATF3
Zip2, we showed that ATF3
Zip2 sensitizes cells to apoptotic cell death in response to tumor necrosis factor-
, at least in part through suppressing nuclear factor (NF)-
B-dependent transcription of anti-apoptotic genes such as cIAP2 and XIAP. ATF3
Zip2 interacts with a p65 (RelA)-cofactor complex containing CBP/p300 and HDAC1 at NF-
B sites of the proximal promoter region of the cIAP2 gene in vivo and down-regulates the recruitment of CBP/p300. Our study revealed that ATF3
Zip2 counteracts anti-apoptotic activity of NF-
B, at least in part, by displacing positive cofactor CBP/p300 and provides insight into the mechanism by which ATF3 regulates cell fate through alternative splicing in stress response.
Received for publication, August 2, 2005 , and in revised form, October 17, 2005.
* This work was supported in part by a grant-in-aid for research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Present address: Research Center for Medical Genomics and Key Laboratory of Cell Biology, Ministry of Health, China Medical University, Shenyang 110001, China.
2 To whom correspondence should be addressed: Dept. of Biochemical Genetics, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. Tel.: 81-3-5803-5822; Fax: 81-3-5803-0248; E-mail: kita.bgen{at}mri.tmd.ac.jp.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Buganim, E. Kalo, R. Brosh, H. Besserglick, I. Nachmany, Y. Rais, P. Stambolsky, X. Tang, M. Milyavsky, I. Shats, et al. Mutant p53 Protects Cells from 12-O-Tetradecanoylphorbol-13-Acetate-Induced Death by Attenuating Activating Transcription Factor 3 Induction. Cancer Res., November 15, 2006; 66(22): 10750 - 10759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guerra, L. A. Lopez-Fernandez, M. A. Garcia, A. Zaballos, and M. Esteban Human Gene Profiling in Response to the Active Protein Kinase, Interferon-induced Serine/threonine Protein Kinase (PKR), in Infected Cells: INVOLVEMENT OF THE TRANSCRIPTION FACTOR ATF-3 IN PKR-INDUCED APOPTOSIS J. Biol. Chem., July 7, 2006; 281(27): 18734 - 18745. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |